logo
Share SHARE
FONT-SIZE Plus   Neg

Credit Suisse Announces Tender Offer To Repurchase Tier 1 & Tier 2 Securities

Credit Suisse (CS) announced a tender offer to repurchase certain outstanding tier 1 and tier 2 securities up to an aggregate amount in cash equivalent to CHF 4 billion.

Credit Suisse has mandated Credit Suisse Securities (Europe) Ltd. as offeror and dealer manager in this transaction.

Based on its strong liquidity and capital position, Credit Suisse unviled a tender offer to repurchase some of its public tier 1 and tier 2 instruments.

Credit Suisse said its main objective is to pro-actively align its capital structure with the proposed Swiss and Basel III regulations and is consistent with Credit Suisse's practice of efficient capital management. It allows the bank's tier 1 and tier 2 investors to sell holdings in capital securities, which over time will be replaced by new capital instruments.

David Mathers, CFO of Credit Suisse Group, said, "This is another important step for Credit Suisse and its investors in transitioning to the new regulatory regime. Credit Suisse continues to take a proactive approach to satisfy the new capital requirements, aimed at transitioning its capital structure well in advance of the required implementation dates.."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT